Elicio TherapeuticsELTX
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 47 institutions reported holding Elicio Therapeutics Inc. (ELTX) in their 13F filings, up 10 from Q4 2025. 16 opened new positions and 7 sold out. The largest holders were Knoll Capital Management, LLC ($6.7M), Vanguard Capital Management LLC ($5.5M) and Balyasny Asset Management L.P. ($2.6M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Elicio Therapeutics Inc.
- CUSIP
- 28657F103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 16 | $3.5M |
| Exits | 7 | $451K |
All 13F filers, Q4 2025 → Q1 2026: 592,380 shares bought and 120,384 shares sold, net +471,996 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| Knoll Capital Management, LLC | 3.57% | No change | 630,915 | $6.7M |
| Vanguard Capital Management LLC | 0.00% | — | 518,638 | $5.5M |
| Balyasny Asset Management L.P. | 0.01% | Add +76.4% | 244,814 | $2.6M |
| Geode Capital Management, LLC | 0.00% | Add +2.0% | 135,164 | $1.4M |
| Renaissance Technologies | 0.00% | Add +332.7% | 121,631 | $1.3M |
| Millennium Management | 0.00% | New | 92,762 | $992K |
| Marshall Wace, LLP | 0.00% | Reduce -36.4% | 74,512 | $797K |
| Susquehanna International Group, LLP | 0.00% | Add +10.5% | 70,804 | $757K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 69,189 | $740K |
| Northern Trust Corp. | 0.00% | Add +13.2% | 59,734 | $639K |
| Goldman Sachs Group Inc. | 0.00% | New | 57,818 | $618K |
| 683 Capital Management, LLC | 0.06% | No change | 56,442 | $603K |
| State Street Corp. | 0.00% | Add +9.3% | 50,620 | $541K |
| BlackRock, Inc. | 0.00% | Add +12.0% | 50,597 | $541K |
| UBS Group AG | 0.00% | Add +5.5% | 33,769 | $361K |
| Morgan Stanley | 0.00% | Add +122.7% | 32,404 | $346K |
| Iridian Asset Management LLC | 0.13% | New | 30,051 | $321K |
| CM Management, LLC | 0.22% | No change | 25,000 | $267K |
| HRT Financial LP | 0.00% | New | 21,611 | $231K |
| Hudson Bay Capital Management LP | 0.00% | New | 20,208 | $216K |
| Brevan Howard Capital Management LP | 0.00% | New | 17,401 | $186K |
| Quadrature Capital Ltd | 0.00% | Reduce -1.4% | 16,912 | $181K |
| Citadel Advisors | 0.00% | New | 15,978 | $171K |
| Bank of America Corp. | 0.00% | Add +1225.2% | 15,333 | $164K |
| Meyer Handelman Co. | 0.00% | No change | 13,899 | $149K |
| Kingswood Wealth Advisors, LLC | 0.01% | New | 13,800 | $148K |
| XTX Topco Ltd | 0.00% | New | 13,785 | $147K |
| Engineers Gate Manager LP | 0.00% | New | 13,160 | $141K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -38.3% | 12,482 | $133K |
| Cresset Asset Management, LLC | 0.00% | New | 11,425 | $122K |
| HighTower Advisors, LLC | 0.00% | Reduce -0.2% | 11,166 | $119K |
| Raymond James Financial Inc. | 0.00% | New | 11,100 | $119K |
| OMERS ADMINISTRATION Corp | 0.00% | Reduce -54.5% | 10,700 | $114K |
| HB Wealth Management, LLC | 0.00% | New | 10,463 | $112K |
| Summit Financial, LLC | 0.00% | No change | 10,010 | $107K |
| Mayflower Financial Advisors, LLC | 0.01% | No change | 10,000 | $107K |
| Moody LYNN Lieberson & Walker, LLC | 0.01% | No change | 10,000 | $107K |
| &partners | 0.00% | No change | 10,000 | $107K |
| BNP Paribas Financial Markets | 0.00% | Add +11.9% | 6,344 | $68K |
| Vanguard Global Advisers, LLC | 0.00% | — | 4,416 | $47K |
| EFG International AG | 0.00% | New | 2,200 | $24K |
| Steward Partners Investment Advisory, LLC | 0.00% | Add +30.2% | 2,023 | $22K |
| Farther Finance Advisors, LLC | 0.00% | Add +2.3% | 721 | $8K |
| SBI Securities Co., Ltd. | 0.00% | No change | 82 | $877 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 3 | $32 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1 | $11 |
| Royal Bank of Canada | 0.00% | Reduce -89.5% | 23 | $0 |
"% of holder's portfolio" is ELTX's weight in each manager's 13F, not the share of Elicio Therapeutics Inc. the manager owns.